337 related articles for article (PubMed ID: 7916335)
41. A comparison of the effects of a subtype selective and non-selective benzodiazepine receptor agonist in two CO(2) models of experimental human anxiety.
Bailey JE; Papadopoulos A; Seddon K; Nutt DJ
J Psychopharmacol; 2009 Mar; 23(2):117-22. PubMed ID: 18562427
[TBL] [Abstract][Full Text] [Related]
42. [Update on benzodiazepines].
Marino A; Costa R
Recenti Prog Med; 1992 May; 83(5):249-54. PubMed ID: 1359614
[TBL] [Abstract][Full Text] [Related]
43. Pinazepam: review of pharmacological properties and therapeutic efficacy.
Janbroers JM
Clin Ther; 1984; 6(4):434-50. PubMed ID: 6147192
[TBL] [Abstract][Full Text] [Related]
44. The present status of benzodiazepines in psychopharmacology.
Iversen LL
Arzneimittelforschung; 1980; 30(5a):907-10. PubMed ID: 6106495
[TBL] [Abstract][Full Text] [Related]
45. [The mechanism of action of benzodiazepine and its consequences for therapy].
Cugurra F
Clin Ter; 1992 Apr; 140(4):331-43. PubMed ID: 1350239
[TBL] [Abstract][Full Text] [Related]
46. Rodent models of anxiety-like behaviors: are they predictive for compounds acting via non-benzodiazepine mechanisms?
Belzung C
Curr Opin Investig Drugs; 2001 Aug; 2(8):1108-11. PubMed ID: 11892922
[TBL] [Abstract][Full Text] [Related]
47. [Pharmacology and clinical aspects of benzodiazepines].
Mendlewicz J; Sevy S
Encephale; 1985; 11(6):255-9. PubMed ID: 2869938
[TBL] [Abstract][Full Text] [Related]
48. [Pharmacological characterization and mechanisms of the novel antidepressive- and/or anxiolytic-like substances identified from Perillae Herba].
Tsuji M; Miyagawa K; Takeuchi T; Takeda H
Nihon Shinkei Seishin Yakurigaku Zasshi; 2008 Aug; 28(4):159-67. PubMed ID: 18800619
[TBL] [Abstract][Full Text] [Related]
49. NS11394 [3'-[5-(1-hydroxy-1-methyl-ethyl)-benzoimidazol-1-yl]-biphenyl-2-carbonitrile], a unique subtype-selective GABAA receptor positive allosteric modulator: in vitro actions, pharmacokinetic properties and in vivo anxiolytic efficacy.
Mirza NR; Larsen JS; Mathiasen C; Jacobsen TA; Munro G; Erichsen HK; Nielsen AN; Troelsen KB; Nielsen EØ; Ahring PK
J Pharmacol Exp Ther; 2008 Dec; 327(3):954-68. PubMed ID: 18791063
[TBL] [Abstract][Full Text] [Related]
50. Pitfalls and prospects in clinical research on antianxiety drugs: benzodiazepines and placebo--a research review.
Solomon K; Hart R
J Clin Psychiatry; 1978 Nov; 39(11):823-31. PubMed ID: 31354
[TBL] [Abstract][Full Text] [Related]
51. The anxiolytic activity of beta-carboline derivatives in mice, and its separation from ataxic properties.
Stephens DN; Kehr W; Wachtel H; Schmiechen R
Pharmacopsychiatry; 1985 Jan; 18(1):167-70. PubMed ID: 2859620
[No Abstract] [Full Text] [Related]
52. [Psychopharmacology and clinical aspects of benzodiazepine dependence].
Apelt S; Schmauss C; Emrich HM
Fortschr Neurol Psychiatr; 1992 Mar; 60(3):104-9. PubMed ID: 1349546
[TBL] [Abstract][Full Text] [Related]
53. A search for a new anticonvulsant and anxiolytic benzodiazepine devoid of side effects and tolerance liability.
Costa E; Auta J; Caruncho H; Guidotti A; Impagnatiello F; Pesold C; Thompson DM
Adv Biochem Psychopharmacol; 1995; 48():75-92. PubMed ID: 7653327
[No Abstract] [Full Text] [Related]
54. [Clinical evaluation of new anxiolytic drugs (author's transl)].
Boulenger JP
Nouv Presse Med; 1982 May; 11(22):1687-94. PubMed ID: 6124934
[TBL] [Abstract][Full Text] [Related]
55. [Neurosteroids--basic principles, anxiolysis and clinical applications].
Hartmann A; Heuser I
Fortschr Neurol Psychiatr; 1996 Nov; 64(11):444-51. PubMed ID: 9064272
[TBL] [Abstract][Full Text] [Related]
56. Buspirone and related compounds as alternative anxiolytics.
Taylor DP; Moon SL
Neuropeptides; 1991 Jul; 19 Suppl():15-9. PubMed ID: 1679210
[TBL] [Abstract][Full Text] [Related]
57. [The serotoninergic mechanisms of anxiety and the action of tranquilizers (a review)].
Komissarova RA; Komissarov IV
Zh Nevropatol Psikhiatr Im S S Korsakova; 1990; 90(5):140-4. PubMed ID: 1975713
[No Abstract] [Full Text] [Related]
58. Antagonists of benzodiazepines.
Haefely W
Encephale; 1983; 9(4 Suppl 2):143B-150B. PubMed ID: 6144509
[TBL] [Abstract][Full Text] [Related]
59. Generalised anxiety disorder: treatment options.
Sramek JJ; Zarotsky V; Cutler NR
Drugs; 2002; 62(11):1635-48. PubMed ID: 12109925
[TBL] [Abstract][Full Text] [Related]
60. Recent developments in anxiety disorders.
Christmas DM; Hood SD
Recent Pat CNS Drug Discov; 2006 Nov; 1(3):289-98. PubMed ID: 18221210
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
